Niall O'Donnell - Feb 16, 2023 Form 4 Insider Report for SPRUCE BIOSCIENCES, INC. (SPRB)

Role
Director
Signature
/s/ Samir Gharib, Attorney-in-Fact
Stock symbol
SPRB
Transactions as of
Feb 16, 2023
Transactions value $
$1,998,368
Form type
4
Date filed
5/16/2023, 04:08 PM
Previous filing
Nov 15, 2022
Next filing
May 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRB Common Stock Purchase $2M +630K +90.59% $3.17 1.33M Feb 16, 2023 By RiverVest Venture Fund IV, L.P. F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPRB Common Stock Warrant (Right to Buy) Purchase +473K 473K Feb 16, 2023 Common Stock 473K $3.96 By RiverVest Venture Fund IV, L.P. F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased in the Issuer's private offering.
F2 Represents the combined purchase price of $3.17 for Common Stock and Warrants acquired from Issuer in a private offering.
F3 RiverVest Venture Partners IV, L.P. is the general partner of RiverVest Venture Fund IV, L.P. The Reporting Person is a manager of RiverVest Venture Partners IV, LLC, the sole general partner of RiverVest Venture Partners IV, L.P., and as a result may be deemed to share dispositive voting and investment power with respect to the shares held by RiverVest Venture Partners IV, L.P. The Reporting Person disclaims beneficial ownership of all shares held by RiverVest Venture Partners IV, L.P. except to the extent of his pecuniary interests therein.
F4 The warrant was purchased in the Issuer's private offering.